Drug Discovery and Development

GE Healthcare partnering on regenerative tissue manufacturing

By |

GE Healthcare Advanced Solutions Life SciencesGE Healthcare Life Sciences said today that it has entered into a strategic R&D and distribution partnership with Advanced Solutions Life Sciences — with a goal of personalized tissue regeneration.

The partnership with Advanced Solutions Life Sciences is the latest in a string of investments and partnerships that GE Healthcare (NYSE:GE) has been making to further a wide array of medtech innovation — from 3D printing to robot-assisted surgery to artificial intelligence to digital health.

The integration of GE’s IN Cell Analyzer with Advanced Solutions Life Sciences’ BioAssemblyBot systems will involve embedding cellular-level assessments into the 3D-bioprinting workflow used to create human tissue models, according to the companies. The deal is about designing, building and imaging living, vascularized 3D tissues in a single process, according to the companies.

Get the full story on our sister site MassDevice. 

Filed Under: Uncategorized
Tagged With: ,
 

About The Author

Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.

Related Articles Read More >

Search Drug Discovery & Development